Anderson S - Search Results

1

Early detection and prognosis of ovarian cancer using serum YKL-40.

Dupont J, Tanwar MK, Thaler HT, Fleisher M, Kauff N, Hensley ML, Sabbatini P, Anderson S, Aghajanian C, Holland EC, Spriggs DR. Dupont J, et al. Among authors: anderson s. J Clin Oncol. 2004 Aug 15;22(16):3330-9. doi: 10.1200/JCO.2004.09.112. J Clin Oncol. 2004. PMID: 15310777 Clinical Trial.

2

Treatment of recurrent ovarian cancer: a retrospective analysis of women treated with single-agent carboplatin originally treated with carboplatin and paclitaxel. The Memorial Sloan-Kettering Cancer Center experience.

Dizon DS, Dupont J, Anderson S, Sabbatini P, Hummer A, Aghajanian C, Spriggs D. Dizon DS, et al. Among authors: anderson s. Gynecol Oncol. 2003 Dec;91(3):584-90. doi: 10.1016/j.ygyno.2003.08.017. Gynecol Oncol. 2003. PMID: 14675681

3

Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma.

Leitao MM, Soslow RA, Nonaka D, Olshen AB, Aghajanian C, Sabbatini P, Dupont J, Hensley M, Sonoda Y, Barakat RR, Anderson S. Leitao MM, et al. Among authors: anderson s. Cancer. 2004 Sep 15;101(6):1455-62. doi: 10.1002/cncr.20521. Cancer. 2004. PMID: 15316901 Free article.

4

Temozolomide in uterine leiomyosarcomas.

Anderson S, Aghajanian C. Anderson S, et al. Gynecol Oncol. 2005 Jul;98(1):99-103. doi: 10.1016/j.ygyno.2005.03.018. Gynecol Oncol. 2005. PMID: 15916799 Review.

5

p53, epidermal growth factor, and platelet-derived growth factor in uterine leiomyosarcoma and leiomyomas.

Anderson SE, Nonaka D, Chuai S, Olshen AB, Chi D, Sabbatini P, Soslow RA. Anderson SE, et al. Int J Gynecol Cancer. 2006 Mar-Apr;16(2):849-53. doi: 10.1111/j.1525-1438.2006.00542.x. Int J Gynecol Cancer. 2006. PMID: 16681772 Clinical Trial.

6

Phase II study of doxorubicin and bevacizumab for patients with metastatic soft-tissue sarcomas.

D'Adamo DR, Anderson SE, Albritton K, Yamada J, Riedel E, Scheu K, Schwartz GK, Chen H, Maki RG. D'Adamo DR, et al. J Clin Oncol. 2005 Oct 1;23(28):7135-42. doi: 10.1200/JCO.2005.16.139. J Clin Oncol. 2005. PMID: 16192597 Clinical Trial.

7

Apoptotic and cell cycle regulatory markers in uterine leiomyosarcoma.

Leiser AL, Anderson SE, Nonaka D, Chuai S, Olshen AB, Chi DS, Soslow RA. Leiser AL, et al. Among authors: anderson se. Gynecol Oncol. 2006 Apr;101(1):86-91. doi: 10.1016/j.ygyno.2005.09.055. Epub 2005 Nov 9. Gynecol Oncol. 2006. PMID: 16289259

8

Phase II trial of 96-hour paclitaxel in previously treated patients with advanced esophageal cancer.

Anderson SE, O'Reilly EM, Kelsen DP, Ilson DH. Anderson SE, et al. Cancer Invest. 2003;21(4):512-6. doi: 10.1081/cnv-120022360. Cancer Invest. 2003. PMID: 14533440 Clinical Trial.

9

Detection of K-ras oncogene mutations in bronchoalveolar lavage fluid for lung cancer diagnosis.

Mills NE, Fishman CL, Scholes J, Anderson SE, Rom WN, Jacobson DR. Mills NE, et al. Among authors: anderson se. J Natl Cancer Inst. 1995 Jul 19;87(14):1056-60. doi: 10.1093/jnci/87.14.1056. J Natl Cancer Inst. 1995. PMID: 7616596

10

Combined modality therapy in esophageal cancer: the Memorial experience.

Anderson SE, Minsky BD, Bains M, Kelsen DP, Ilson DH. Anderson SE, et al. Semin Surg Oncol. 2003;21(4):228-32. doi: 10.1002/ssu.10041. Semin Surg Oncol. 2003. PMID: 14648780

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,643 results

Search Page

Filters